What should be paid attention to in daily life with dilated cardiomyopathy?

Written by Li Hai Wen
Cardiology
Updated on January 15, 2025
00:00
00:00

For dilated cardiomyopathy, attention should be paid to the following two aspects:

First, maintain good living habits, such as a low-salt diet, abstaining from smoking and alcohol, and adhering to appropriate exercise when the condition is stable. At the same time, try to avoid staying up late and excessive fatigue.

Second, standardized medication treatment should be carried out under the guidance of a doctor. This includes drugs such as the diuretic furosemide or spironolactone, as well as beta-blockers like metoprolol sustained-release tablets. Proper medication can improve symptoms, reduce the occurrence of heart failure, and lessen hospital visits, thereby improving life quality and extending life span. Never stop or switch any medication on your own at home.

(Please consult a doctor before using any medication)

Other Voices

doctor image
home-news-image
Written by Li Hai Wen
Cardiology
51sec home-news-image

What should be paid attention to in daily life with dilated cardiomyopathy?

For dilated cardiomyopathy, attention should be paid to the following two aspects: First, maintain good living habits, such as a low-salt diet, abstaining from smoking and alcohol, and adhering to appropriate exercise when the condition is stable. At the same time, try to avoid staying up late and excessive fatigue. Second, standardized medication treatment should be carried out under the guidance of a doctor. This includes drugs such as the diuretic furosemide or spironolactone, as well as beta-blockers like metoprolol sustained-release tablets. Proper medication can improve symptoms, reduce the occurrence of heart failure, and lessen hospital visits, thereby improving life quality and extending life span. Never stop or switch any medication on your own at home. (Please consult a doctor before using any medication)

doctor image
home-news-image
Written by Tang Li
Cardiology
1min 14sec home-news-image

What is the prognosis of hypertrophic cardiomyopathy?

The prognosis of hypertrophic cardiomyopathy varies greatly, and it is the primary cause of sudden death in adolescents and athletes because it can progress to end-stage heart failure. Additionally, a small percentage may experience heart failure, atrial fibrillation, and embolism, but many patients have mild symptoms and can have a life expectancy close to normal. For the treatment of hypertrophic cardiomyopathy, adequate sudden death risk assessment and ICD prevention should be conducted. Because hypertrophic cardiomyopathy is the most common cause of sudden cardiac death in young people and athletes, an ICD can effectively prevent the occurrence of sudden death. Preventing high-risk factors, including previous cardiac arrest, one or more sudden deaths in first-degree relatives, severe left ventricular hypertrophy, and findings of repetitive non-sustained ventricular tachycardia on a 24-hour Holter monitor, low blood pressure during exercise, and unexplained syncope, especially during exercise, poses a high risk of sudden death in these patients.

doctor image
home-news-image
Written by Tang Li
Cardiology
1min 38sec home-news-image

How is hypertrophic cardiomyopathy treated?

The treatment of hypertrophic cardiomyopathy aims to improve symptoms, reduce complications, and prevent sudden death. The methods include improving ventricular compliance by reducing outflow tract obstruction, preventing thromboembolic events, and identifying high-risk patients for sudden death. Treatment needs to be individualized, and the main treatments include the following aspects: 1. Medication treatment. Drug treatment is fundamental, and drugs targeting outflow tract obstruction mainly include receptor blockers and non-dihydropyridine calcium channel blockers. For patients with congestive heart failure, targeted treatment is required. Anticoagulation treatment is necessary for patients with atrial fibrillation, and it is worth noting that for patients with chest discomfort, care should be taken to exclude outflow tract obstruction when using nitrate drugs to avoid exacerbation after use. Non-drug treatments include: 1. Surgical treatment: For patients with ineffective drug treatment and heart function class three to four, if there is severe outflow tract obstruction, septal myectomy should be considered. Currently, surgery is listed as the preferred treatment for suitable patients in consensus guidelines in both America and Europe. 2. Alcohol septal ablation; 3. Pacing therapy.

doctor image
home-news-image
Written by Zhang Yue Mei
Cardiology
39sec home-news-image

Can people with cardiomyopathy run?

Whether a person with myocardial disease can run or not depends on the extent of myocardial damage and clinical symptoms. If the myocardial damage is severe and there are significant clinical symptoms of heart failure and arrhythmia, this group should not run and needs bed rest. If strenuous activity would worsen heart failure, the myocardial damage is mild, with no typical clinical symptoms, and does not affect daily activities, this group can engage in appropriate exercises like walking or running, but the duration should not be too long, about 20 to 30 minutes each time.

doctor image
home-news-image
Written by Tang Li
Cardiology
1min 15sec home-news-image

Treatment of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, due to unknown causes and often related to genetic factors, is difficult to prevent. It is important to guide patients on how to lead their lives, reminding them to avoid intense physical activities, heavy lifting, or breath-holding to reduce the incidence of sudden death. Avoid using drugs that enhance myocardial contractility and reduce cardiac capacity load, such as digoxin and nitrates, to decrease the aggravation of left ventricular outflow tract obstruction. The treatment principle for this disease is to slow down the hypertrophy of the myocardium, prevent tachycardia, and maintain normal sinus rhythm. It also aims to relieve the narrowing of the left ventricular outflow tract and counteract arrhythmias. Currently, the use of beta blockers and calcium channel blockers is advocated. For severe obstructive patients, interventional and surgical treatments can be carried out, including the implantation of a dual-chamber DTD pacemaker, and the ablation or removal of hypertrophied interventricular septum myocardium.